The present invention generally relates to systems and methods for the
production of high amounts of personalized interferons (IFNs), which are
IFNs produced from the cells of the patient to whom the IFN is to be
administered, for therapeutic and research uses. The system can also be
used to produce high amounts of natural IFNs.